What should you know about deucravacitinib and psoriatic arthritis?

Psoriatic arthritis is an inflammatory condition that can affect joints, tendons, fingers, toes, and the spine, often alongside psoriasis. [Joint Pain](/symptoms/joint-pain/), [Joint Swelling](/symptoms/joint-swelling/), and [Morning Joint Stiffness](/symptoms/morning-joint-stiffness/) can signal active inflammation, but they do not identify one cause by themselves. Deucravacitinib changes a specific immune signalling pathway. Whether it is appropriate depends on the exact diagnosis, local prescribing information, previous medicines, infections, liver health, and other medical factors.

Do not start, stop, or share this medicine without the prescriber who knows your history. Bring a list of medicines, supplements, infections, vaccinations, and previous treatment responses to the appointment. Ask how monitoring will be arranged and what improvement should be tracked. A plan may also include [Anti-Inflammatory Medication](/treatments/non-surgical-orthopedics/anti-inflammatory-medication/) for symptoms and [Physiotherapy](/treatments/physiotherapy-and-rehabilitation/physiotherapy/) to preserve movement, strength, and joint protection.

Contact the prescribing team promptly for fever, a persistent cough, painful urination, unusual bruising, yellowing of the skin, or a marked change in health after starting treatment. Seek emergency help for trouble breathing, facial swelling, severe weakness, or a serious allergic reaction. A suddenly hot swollen joint with fever also needs urgent assessment because infection can resemble inflammation.

Ask whether this medicine is approved and suitable for your psoriatic arthritis, which tests and vaccines are needed, how interactions will be checked, and what to do if a dose is missed or an infection develops.